The correlation between metabolic syndrome and prostatic diseases.
about
Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptomsTadalafil for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a review of clinical data in Asian men and an update on the mechanism of actionThe role of phosphodiesterase-5 inhibitors in prostatic inflammation: a reviewMetabolic syndrome and diabetes for the urologistDiabetes, insulin resistance, and metabolic syndrome in horsesMetabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: results from a multicentre prospective studyMetabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.Lifestyle and health factors associated with progressing and remitting trajectories of untreated lower urinary tract symptoms among elderly men.Erythrocyte stiffness during morphological remodeling induced by carbon ion radiationMechanisms of synergism between antagonists of growth hormone-releasing hormone and antagonists of luteinizing hormone-releasing hormone in shrinking experimental benign prostatic hyperplasia.Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia.Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in FranceIs there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies.Effect of Silodosin, an Alpha1A-Adrenoceptor Antagonist, on Ventral Prostatic Hyperplasia in the Spontaneously Hypertensive Rat.Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, CanadaBenign prostatic hyperplasia complicated with T1DM can be alleviated by treadmill exercise-evidences revealed by the rat modelMetabolic syndrome diagnosis and widespread high grade prostatic intraepithelial neoplasia significantly increase prostate cancer risk: results from a multicenter biopsy study.Anoctamin 1 (TMEM16A) is essential for testosterone-induced prostate hyperplasia.Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) studyAnthropometric Measures at Multiple Times Throughout Life and Prostate Cancer Diagnosis, Metastasis, and DeathHeart healthy equals prostate healthy and statins, aspirin, and/or metformin (S.A.M.) are the ideal recommendations for prostate cancer preventionAlcohol, Smoking, Physical Activity, Protein, and Lower Urinary Tract Symptoms: Prospective Longitudinal Cohort.PPARγ isoforms differentially regulate metabolic networks to mediate mouse prostatic epithelial differentiation.Metabolic syndrome and benign prostatic hyperplasia: association or coincidence?Prostate cancer in patients with metabolic syndrome is associated with low grade Gleason score when diagnosed on biopsy.Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study.The evaluation of the association between the metabolic syndrome and tumor grade and stage of bladder cancer in a Chinese population.Preventing aggressive prostate cancer with proven cardiovascular disease preventive methodsRelationship between Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia and Metabolic Syndrome in Korean Men.Challenging the Inevitability of Prostate Enlargement: Low Levels of Benign Prostatic Hyperplasia Among Tsimane Forager-HorticulturalistsThe Association Between Metabolic Syndrome and Characteristics of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis.Associations between metabolic syndrome and clinical benign prostatic hyperplasia in a northern urban Han Chinese population: A prospective cohort study.The effect of obesity and components of metabolic syndrome on urinary and sexual functions in Saudi menObesity as a Risk Factor for Prostatic Enlargement: A Retrospective Cohort Study in Korea.Is metabolic syndrome truly a risk factor for male lower urinary tract symptoms or just an epiphenomenon?Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions.Metabolic syndrome and prostate abnormalities in male subjects of infertile couples.The association between sexual function and prostate cancer risk in US veterans.Parental High-Fat Diet Promotes Inflammatory and Senescence-Related Changes in ProstateCD8+ T cells promote proliferation of benign prostatic hyperplasia epithelial cells under low androgen level via modulation of CCL5/STAT5/CCND1 signaling pathway.
P2860
Q21256691-516B4A9C-F785-4864-96A1-5B5AF22F4028Q26783529-59F0F21F-B0CB-4DDD-A000-C98EAD64CAB9Q26785428-AA733F96-3A00-4AEE-A70D-3E43FC0C8972Q26830106-6292D75E-90B5-413E-98CC-301DAC06BF9BQ27010200-7D2514C4-00AB-436E-8C85-E34448CCF8E9Q28596648-720EF61F-C541-4643-811B-19BAE92CB649Q34408679-FE524DBB-7537-4984-ADCF-F486D71D67D8Q34425753-4A06F21C-1B0E-48D5-B555-0E06F74F8712Q34524784-70A89064-CD95-49D2-9CAD-A2E40BD57F42Q34529072-C8A0EDA0-DC48-4D26-BCA9-8EA034BACA58Q34698236-6A9F461A-E2EA-4239-8BAC-DE92DF478512Q35098158-7A64EBEE-67E3-447D-9DE8-E779795E4DBFQ35510256-440511C9-087F-4B25-81C9-4755EE5A9F37Q35755940-7721A90A-DF73-40FB-B660-8C3DD9F4876EQ35781093-62F122B6-9F2C-4A97-B532-B9744D748FEEQ35843929-33FD904A-90FC-414D-96B0-AF671B783FA2Q35914795-2A6777C6-77DA-4CFA-93ED-CC9327EEE633Q35946332-BCF24ADD-4672-4031-8312-F6A8D47FE0FDQ36044730-D73ED960-CE3B-45F2-A21A-CDB3DB05D9C4Q36070376-ACB99D1C-C0D6-434F-A7A4-42ECDB7488EBQ36080332-23E0F50B-FE90-4629-A57F-16225DE48438Q36090790-FFEDCD7E-9BB3-448C-859A-9A4966F40775Q36211459-D00B3591-80D3-4C99-A390-C5D21BBADA29Q36224259-A92861E2-E561-4FD6-B197-CF4BC9F60A28Q36284738-E3C0CF37-6CAC-402C-B8F2-AF11EDDABD4CQ36334566-0B09CD94-3540-412E-9559-C7651B56D6B8Q36682363-A3C6D014-4C77-43D1-9868-06EED2BF0DC7Q36748541-959FB5E6-82BB-4B86-9E98-D82BD3BA8A56Q36758168-8588E018-3653-41DF-83C8-4B8F9DE8E308Q36853498-C2504A11-BBA6-4029-AA55-6DEF44FB43B8Q36993287-DF47D1FA-468C-47B0-AC9C-020718F2B71DQ37274150-266111D6-B39F-412B-A00F-CB6DB451BAB7Q37306092-B6F19DAB-973F-403F-BBD2-DF0C157667C9Q37553992-22AE4972-CF8C-4DD1-8C54-3B268367ADDBQ37577512-313383D5-17B6-47A9-AFBE-8202C6A7A58AQ37618958-A2626675-AD59-47D1-8E53-2E90B24393DFQ37639222-9AC29CCB-1D12-4A75-8961-0D4A09BEF82AQ37644663-762E44E4-EFFA-4308-8C70-856F53BA3C73Q37651500-DCDAFAD1-057C-4F82-95E1-9A7F423842E6Q37652222-89E693EC-FE2E-4DF9-A7B6-7E80ACB6514D
P2860
The correlation between metabolic syndrome and prostatic diseases.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
The correlation between metabolic syndrome and prostatic diseases.
@en
The correlation between metabolic syndrome and prostatic diseases.
@nl
type
label
The correlation between metabolic syndrome and prostatic diseases.
@en
The correlation between metabolic syndrome and prostatic diseases.
@nl
prefLabel
The correlation between metabolic syndrome and prostatic diseases.
@en
The correlation between metabolic syndrome and prostatic diseases.
@nl
P2093
P1433
P1476
The correlation between metabolic syndrome and prostatic diseases.
@en
P2093
Edward Giovannucci
J Kellogg Parsons
Stephen J Freedland
William Aronson
P304
P356
10.1016/J.EURURO.2011.11.013
P407
P577
2011-11-15T00:00:00Z